BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30652414)

  • 1. Long noncoding RNA DNAJC3-AS1 promotes osteosarcoma progression via its sense-cognate gene DNAJC3.
    Liang R; Liu Z; Chen Z; Yang Y; Li Y; Cui Z; Chen A; Long Z; Chen J; Lu J; Huang B; Li Q
    Cancer Med; 2019 Feb; 8(2):761-772. PubMed ID: 30652414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
    Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
    Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
    Liu ZB; Wang JA; Lv RQ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
    Chen S; Li W; Guo A
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SP1-mediated upregulation of lncRNA ILF3-AS1 functions a ceRNA for miR-212 to contribute to osteosarcoma progression via modulation of SOX5.
    Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
    Biochem Biophys Res Commun; 2019 Apr; 511(3):510-517. PubMed ID: 30819403
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Luo Y; Tao H; Jin L; Xiang W; Guo W
    Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
    [No Abstract]   [Full Text] [Related]  

  • 7. LncRNA DNAJC3-AS1 promotes the biological functions of papillary thyroid carcinoma via regulating the microRNA-27a-3p/CCBE1 axis.
    Ni T; Li Y; Guo D; Tan L; Xiao Z; Shi Y
    Cell Biol Int; 2023 Mar; 47(3):539-547. PubMed ID: 36583660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SP1-mediated upregulation of lncRNA LMCD1-AS1 functions a ceRNA for miR-106b-5p to facilitate osteosarcoma progression.
    He JW; Li DJ; Zhou JH; Zhu YL; Yu BQ
    Biochem Biophys Res Commun; 2020 Jun; 526(3):670-677. PubMed ID: 32248969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
    Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
    Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma.
    Cai L; Lv J; Zhang Y; Li J; Wang Y; Yang H
    J Cell Mol Med; 2017 Nov; 21(11):2654-2662. PubMed ID: 28866868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
    Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C
    Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA MATN1-AS1 for Prediction of Prognosis in Osteosarcoma Patients and Its Cellular Function.
    Liu Y; Wang D; Ji Q; Yan J
    Mol Biotechnol; 2022 Jan; 64(1):66-74. PubMed ID: 34542816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
    Chen F; Mo J; Zhang L
    Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
    Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
    Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223.
    Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X
    Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142.
    Yang G; Song R; Wang L; Wu X
    Biomed Pharmacother; 2018 Jul; 103():1238-1245. PubMed ID: 29864904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNK2-AS1 upregulated by YY1 boosts the course of osteosarcoma through targeting miR-4319/WDR1.
    Yao W; Yan Q; Du X; Hou J
    Cancer Sci; 2021 Feb; 112(2):893-905. PubMed ID: 33164271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway.
    Shi D; Wu F; Mu S; Hu B; Zhong B; Gao F; Qing X; Liu J; Zhang Z; Shao Z
    J Exp Clin Cancer Res; 2019 Aug; 38(1):375. PubMed ID: 31443665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense lncRNA FOXF1-AS1 Promotes Migration and Invasion of Osteosarcoma Cells Through the FOXF1/MMP-2/-9 Pathway.
    Kun-Peng Z; Chun-Lin Z; Xiao-Long M
    Int J Biol Sci; 2017; 13(9):1180-1191. PubMed ID: 29104509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2.
    Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J
    Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.